Custom Synthesis And Green Chemistry Will Harness Rising Pharmaceutical Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 29 Analysts
Published
10 Jun 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
₹7,750.00
20.6% undervalued intrinsic discount20 Aug
₹6,151.50
1Y
26.7%7D
0.3%